du.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • chicago-author-date
  • chicago-note-bibliography
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Applicatiion of Almost ideal demand system for a pharmaceutical
Dalarna University, School of Technology and Business Studies, Economics.
2008 (English)Independent thesis Advanced level (degree of Master (Two Years))Student thesis
Abstract [en]

This thesis is an application of the Almost Ideal Demand System approach of Deaton and Muellbauer,1980, for a particular pharmaceutical, Citalopram, in which GORMAN´s (1971) multi-stage budgeting approach is applied basically since it is one of the most useful approach in estimating demand for differentiated products. Citalopram is an antidepressant drug that is used in the treatment of major depression. As for most other pharmaceuticals whose the patent has expired, there exist branded and generic versions of Citalopram. This paper is aimed to define its demand system with two stage models for the branded version and five generic versions, and to show whether generic versions are able to compete with the branded version. I calculated the own price elasticities, and it made me possible to compare and make a conclusion about the consumers’ choices over the brand and generic drugs. Even though the models need for being developed with some additional variables, estimation results of models and uncompensated price elasticities indicated that the branded version has still power in the market, and generics are able to compete with lower prices. One important point that has to be taken into consideration is that the Swedish pharmaceutical market faced a reform on October 1, 2002, that aims to make consumer better informed about the price and decrease the overall expenditures for pharmaceuticals. Since there were not significantly enough generic sales to take into calculation before the reform, my paper covers sales after the reform.

Place, publisher, year, edition, pages
Borlänge, 2008. , 43 p.
Identifiers
URN: urn:nbn:se:du-3722OAI: oai:dalea.du.se:3722DiVA: diva2:518584
Uppsok
Social and Behavioural Science, Law
Supervisors
Available from: 2009-02-17 Created: 2009-02-17 Last updated: 2012-04-24Bibliographically approved

Open Access in DiVA

fulltext(746 kB)3071 downloads
File information
File name FULLTEXT01.pdfFile size 746 kBChecksum SHA-512
9065e2a9bd391abcd535366e1eff897cac1d3f5ca23dd39f969a0518063d2e3220df7c52a0770e75db30e436dc1a3c1b6e8381bd2f5332a36cb748c19cb448b0
Type fulltextMimetype application/pdf

By organisation
Economics

Search outside of DiVA

GoogleGoogle Scholar
Total: 3071 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 621 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • chicago-author-date
  • chicago-note-bibliography
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf